MedPath

Auto-PAP Therapy For Improved Fetal Growth

Not Applicable
Completed
Conditions
Pregnancy
Obstructive Sleep Apnea
Interventions
Device: Auto-PAP
Registration Number
NCT03318003
Lead Sponsor
University of Michigan
Brief Summary

The purpose of this study is to see whether the presence of night-time breathing disturbances ("sleep-disordered breathing") in pregnant women is related to fetal growth patterns. The hypothesis is that fetal growth slows in the 3rd trimester in women with sleep-disordered breathing. Use of a nighttime breathing therapy called auto-PAP could minimize the slowing in fetal growth.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
43
Inclusion Criteria
  • at least 18 years old;
  • no more than 20 weeks pregnant;
  • pregnant with one baby;
  • found to have sleep-disordered breathing as measured by a sleep study. If you are found to have severe sleep apnea on the sleep study you will be referred for clinical care instead of participating in the study.
Read More
Exclusion Criteria
  • more than 20 weeks pregnant;
  • pregnant with twins, triplets, or more babies;
  • a current smoker, drink alcohol, or use recreational drugs;
  • currently using positive-airway pressure therapy for treatment of obstructive sleep apnea;
  • diagnosed with certain conditions such as bullous lung disease, a bypassed upper airway, pneumothorax (collapsed lung), pneumocephalus (leak of cerebrospinal fluid, the fluid that the brain and spine float in), if you have had recent trauma, or recent nasal surgery.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Auto-PAP TherapyAuto-PAP-
Primary Outcome Measures
NameTimeMethod
Number of Participants With Slowing of Fetal Growth by 33% or More During the Last Trimester3rd trimester

A slowing of fetal growth will be defined as a slowing of fetal growth by \>=33% during the last trimester

Secondary Outcome Measures
NameTimeMethod
Presence or Absence of Placental HypoxiaAt delivery the placenta will be collected and processed.

The placenta will be reviewed by a pathologist to determine the presence or absence of areas of hypoxia

Trial Locations

Locations (1)

University of Michigan Heath System

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath